immunodeficiency

Documents about immunodeficiency

• A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency#874311ClinicalTrials.gov
• Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency#847875ClinicalTrials.gov
• Treatment of Adult-Onset Immunodeficiency With Bortezomib#894695ClinicalTrials.gov
• ICVAX as a HIV Therapeutic DNA Vaccine#143663ClinicalTrials.gov
• Improving the Diagnosis of Common Variable Immune Deficiency#870799ClinicalTrials.gov
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders#909066ClinicalTrials.gov
• Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition#220414Figshare
• Peripheral Helper T-cells in Common Variable ImmunoDeficiency#916597ClinicalTrials.gov
• Clinical data for primary immunodeficiency patients#260345Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Human Immunodeficiency Virus (HIV)#339164Southampton
• Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome#967332ClinicalTrials.gov
• Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment#992781ClinicalTrials.gov
• HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong#28427ClinicalTrials.gov
• Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency#854961ClinicalTrials.gov
• Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant#833919ClinicalTrials.gov
• Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia#861317ClinicalTrials.gov
• Expanded Access to TAK-881 for People With Primary Immunodeficiency Diseases in the USA and Czech Republic#894454ClinicalTrials.gov
• Generalized Neonatal Screening of Severe Combined Immunodeficiencies#917707ClinicalTrials.gov
• Intensive Care Unit and Secondary and Primary Immune Deficiency#993547ClinicalTrials.gov
• HCV/HIV Coinfection: Antiviral Therapy and Fibrosis#915202ClinicalTrials.gov
• Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients#915918ClinicalTrials.gov
• Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)#853762ClinicalTrials.gov
• Relaxation Response With Acupuncture for HIV Patients#980798ClinicalTrials.gov
• An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study#842673ClinicalTrials.gov
• Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector#894236ClinicalTrials.gov
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults#871319ClinicalTrials.gov
• Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID#882513ClinicalTrials.gov
• GLILD Diagnosed in Children and Young Adults With Common Variable Immunodeficiency#907689ClinicalTrials.gov
• Address by Dr Mahmoud Fikri Regional Director WHO Eastern Mediterranean Region to the Middle East and North Africa Regional co-sponsors meeting, Cairo, Egypt, 11 April 2017#286823WHO IRIS
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)#838597ClinicalTrials.gov
• The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo#850096ClinicalTrials.gov
• PRO 140 for Human Immunodeficiency Virus Infection#890829ClinicalTrials.gov
• Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older#891936ClinicalTrials.gov
• Contributions of the gp120 Variable Loops to Envelope Glycoprotein Trimer Stability in Primate Lentiviruses#995699DigitalCommons@University of Nebraska
• Guidelines for nursing management of people infected with human immunodeficiency virus (HIV)#466862WHO IRIS
• Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)#885401ClinicalTrials.gov
• Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women#848427ClinicalTrials.gov
• Magnesium Supplementation in People With XMEN Syndrome#917586ClinicalTrials.gov
• Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency#829151ClinicalTrials.gov
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children#887036ClinicalTrials.gov
• A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435#908630ClinicalTrials.gov
• Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)#993774ClinicalTrials.gov
• Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy#866774ClinicalTrials.gov
• Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence#870109ClinicalTrials.gov
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• HIV Medication Adherence in Underserved Populations#899206ClinicalTrials.gov
• Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency#449013IRIS
• GSK1349572 Relative Bioavailability Study#874734ClinicalTrials.gov
• cliniMACs HUD for T Cell Depletion#880821ClinicalTrials.gov
• Vaccine-induced Immunity in Immunocompromised Patients#912952ClinicalTrials.gov